“Galderma maintains a close working relationship with the INRIA teams through research work on the mathematical models involved in image processing, essential for improving the readability of symptoms. Furthermore, the presence of INPI is also interesting. To protect its discoveries, Galderma has filed over 50 new sets of patent applications (covering new molecules, formulations, dermatological indications and some manufacturing processes) thus making it the company filing the most patents in the Alpes-Maritimes and the second largest in the PACA region”, explains Frédéric Fourquin, former CERAM student (now SKEMA), Manager of the Sophia Antipolis site.
A world leading medical company exclusively focused on dermatology, Galderma, founded in 1981, is committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 31 wholly-owned affiliates with a worldwide network of distributors and more than 4,000 employees. Galderma’s extensive product portfolio is available in 70 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence.